0 results for 'Eric Company'
Asia Deal Digest: Nov. 13, 2014
*Five firms on near billion-dollar offer by CITIC, KKR for Singapore's United Envirotech*Jones Day, Milbank lead Philippines retailer SSI Group on its recent IPO*Clifford Chance acts for Australia's AMP as it buys a stake in China Life PensionSullivan & Cromwell, Magic Circle Duo on $5.4B Hutchison Bond
Sullivan & Cromwell and Freshfields advise the Hong Kong conglomerate with Allen & Overy acting for the banks.Five Firms on $1.95 Billion Waldorf Astoria Deal
Skadden, Fried Frank, Greenberg Traurig, Simpson Thacher and Dentons all have roles on a Chinese company's purchase of the landmark New York hotel.Asia Deal Digest: Sept. 11, 2014
*Linklaters leads establishment of China Orient Asset Management's $2 billion medium-term note program*Jones Day acts for Japan's Ajinomoto on its $800 million offer for U.S. frozen-foods maker Windsor Quality*Rajah & Tann on KMP Private Ltd.'s $37 million investment in Vietnamese feed company Hiep Thanh GroupEC Antitrust Chief May Seek New Concessions from Google
As opposition to Google's settlement with the European Commission rises, Competition Commissioner Joaquin Almunia says he will revisit the agreement struck in February.View more book results for the query "Eric Company"
Asia Deal Digest: Aug. 28, 2014
*Kirkland & Ellis advises Orchid Asia on $920 million China fund *HSF, KWM lead AGL's $1.1 billion rights issue for MacGen acquisition *Simpson Thacher, Gunderson Dettmer on Murata's $465 million acquisition of chipmaker PeregrineTwo Am Law Firms Advise on Oak Hill's $1.43 Billion Deal
Gibson Dunn and Paul Weiss provided legal counsel on private equity firm Oak Hill Capital Partners' acquisition of container maker Berlin Packaging LLC from Bahrain-based investment firm Investcorp Bank BSC.Cravath, Davis Polk Lead on Latest Big Drug Buy
In its biggest deal since its $46.8 billion takeover of Genentech in 2009, Swiss drug giant Roche has turned to Davis Polk & Wardwell for counsel on its $8.3 billion buy of suburban San Francisco-based lung disease drug developer InterMune, which is being advised by Cravath, Swaine & Moore and a Chicago IP boutique.U.S. Court Upholds AU Optronics' Price-Fixing Convictions
The Justice Department had authority to pursue the Taiwan-based company because millions of panels were imported into the U.S., Judge M. Margaret McKeown wrote.Countdown to Compliance: SEC Private Fund Reforms
Brought to you by Ontra
Download Now
Top 10 Compliance Concerns for Private Fund Managers
Brought to you by Ontra
Download Now
The Top 10 Terms in Private Equity NDAs
Brought to you by Ontra
Download Now